Combination of Gemcitabine and Cisplatin as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer

PURPOSE: The prognosis of patients with advanced non-small-cell lung cancer (NSCLC) is extremely poor. Many prospective randomized trials on patients with advanced NSCLC suggested systemic chemotherapy improves both the survival and quality of life. A phase II trial was conducted to evaluate the eff...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lee, Nam-Su, Byun, Jae-Ho, Bae, Sang-Byung, Kim, Chan-Kyu, Lee, Kyu-Taeg, Park, Sung-Kyu, Won, Jong-Ho, Hong, Dae-Sik, Park, Hee-Sook
Formato: Artigo
Idioma:Inglês
Publicado: Korean Cancer Association 2004
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2855082/
https://ncbi.nlm.nih.gov/pubmed/20396540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2004.36.3.173
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares